Skip to main content
Log in

Comparative In Vitro Antibacterial Activity of PD 131628, the Active Metabolite of CI-990

  • Poster Presentations
  • New Quinolones
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Cohen MA, Huband MD, Mailloux GB, Yoder SL, Roland GE, et al. In-vitro antibacterial activities of PD 131628, anew 1,8 naphthyridine antiinfective agent. Antimicrobial Agents and Chemotherapy 35: 141–146, 1991

    Article  PubMed  CAS  Google Scholar 

  • Fuchs PC, Barry AL, Phaller MA, Allen SD, Gerlach EH. Multicenter evaluation of the in-vitro activities of three new quinolones, sparfloxacin, CI-960 and PD131628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates. Antimicrobial Agents and Chemotherapy 35: 664–766, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Callanan, J.J., Roditi, D.O.J. & Forder, A.A. Comparative In Vitro Antibacterial Activity of PD 131628, the Active Metabolite of CI-990. Drugs 45 (Suppl 3), 192–193 (1993). https://doi.org/10.2165/00003495-199300453-00047

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199300453-00047

Keywords

Navigation